Supplier
Unicare Pharmacy INC
Unicare Pharmacy INC was paid $8.08M by Medicaid between Jan 2018 and Nov 2024, across 52 billing codes. Its largest line is J0135, Injection, adalimumab, 20 mg — 14% of everything it billed.
33Billing provider infoUNICARE PHARMACY INC
VAN NUYS, CA 91406
VAN NUYS, CA 91406
33aNPI1255644357assigned 07/17/2010
33bProvider typePharmacy
28Total paid$8.08M
24GClaims20,839
24DCodes billed52
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pharmacy providers in California
Rank by total paid#7 of 179
Median peer was paid$2K
This provider vs. median4,581×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,792 | $326K | |
| 2019 | 4,741 | $1.03M | |
| 2020 | 5,667 | $2.04M | |
| 2021 | 4,540 | $3.61M | |
| 2022 | 1,039 | $59K | |
| 2023 | 353 | $426K | |
| 2024incomplete | 707 | $588K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0135 | Injection, adalimumab, 20 mg | 14% | 547 | 511 | $1.12M |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 12% | 894 | 891 | $968K |
| J3490 | Unclassified drugs | 8.0% | 1,843 | 1,647 | $650K |
| J0897 | Injection, denosumab, 1 mg | 7.9% | 457 | 440 | $642K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 7.5% | 591 | 584 | $603K |
| J3590 | Unclassified biologics | 7.1% | 666 | 636 | $577K |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 6.4% | 182 | 134 | $515K |
| J9271 | Injection, pembrolizumab, 1 mg | 6.1% | 66 | 54 | $496K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 4.0% | 252 | 246 | $324K |
| 99601 | 3.9% | 3,832 | 940 | $315K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3.4% | 1,173 | 976 | $275K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 3.1% | 397 | 395 | $251K |
40 more codes
| J9035 | Injection, bevacizumab, 10 mg | 2.7% | 61 | $222K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2.3% | 810 | $183K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.9% | 769 | $150K |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | 1.7% | 77 | $138K |
| J9306 | Injection, pertuzumab, 1 mg | 1.6% | 36 | $126K |
| B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | 1.1% | 595 | $86K |
| J1438 | Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | <1% | 63 | $70K |
| S9500 | Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 77 | $53K |
| 90750 | <1% | 478 | $51K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 178 | $50K |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 40 | $32K |
| S9542 | Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 783 | $28K |
| S0028 | Injection, famotidine, 20 mg | <1% | 290 | $28K |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 162 | $26K |
| A4223 | Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately) | <1% | 1,073 | $26K |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | <1% | 38 | $20K |
| 90715 | <1% | 351 | $16K | |
| S9374 | Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 65 | $9K |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | <1% | 13 | $6K |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | <1% | 37 | $3K |
| A4230 | Infusion set for external insulin pump, non needle cannula type | <1% | 327 | $3K |
| A4927 | Gloves, non-sterile, per 100 | <1% | 1,329 | $2K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 132 | $2K |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 28 | $2K |
| 99602 | Nursing care in home rn | <1% | 15 | $2K |
| J2505 | Injection, pegfilgrastim, 6 mg | <1% | 22 | $1K |
| J9045 | Injection, carboplatin, 50 mg | <1% | 16 | $1K |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 90 | $995.42 |
| A4212 | Non-coring needle or stylet with or without catheter | <1% | 89 | $986.60 |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 37 | $828.69 |
| E0776 | Iv pole | <1% | 12 | $821.81 |
| A4245 | Alcohol wipes, per box | <1% | 1,174 | $764.57 |
| J9263 | Injection, oxaliplatin, 0.5 mg | <1% | 17 | $559.68 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 37 | $505.27 |
| A4231 | Infusion set for external insulin pump, needle type | <1% | 69 | $339.11 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 25 | $311.90 |
| J9070 | Cyclophosphamide, 100 mg | <1% | 22 | $207.66 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 66 | $191.30 |
| A6210 | Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing | <1% | 418 | $45.58 |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRIEDMAN, SCOTT (EXECUTIVE VP)
| Provider | Location | Paid |
|---|---|---|
| Island Orthodontic,pllc | Lake Ronkonkoma, NY | $2.17M |
| North Fork Orthodontics, P.C. | Riverhead, NY | $1.24M |
| Bracetown Orthodontics, LLP | Astoria, NY | $1.04M |
| All Smiles Orthodontics, PLLC | Astoria, NY | $491K |
| North Shore Orthodontics | Whitestone, NY | $375K |
| Florida Retina Consultants P.A. | Lakeland, FL | $984.31 |
| Horizon Orthodontics,pllc | Holtsville, NY | $846.08 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.